Medical Equipment

Immunodiagnostics Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Immunodiagnostics Market During 2026–2030?

The immunodiagnostics market size has demonstrated robust growth over the past few years. It is anticipated to expand from $24.32 billion in 2025 to $26.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The expansion observed in the historic period was primarily driven by the increasing occurrence of infectious and chronic diseases, the enlargement of clinical laboratory networks, a rising need for early disease detection, the growing utilization of antibody-based diagnostics, and the accessibility of standardized immunoassay technologies.

The immunodiagnostics market is anticipated to experience robust expansion in the coming years. It is projected to reach $35.76 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This expansion over the forecast period is primarily driven by factors such as the increasing embrace of personalized diagnostics, heightened investments in automated laboratories, the broadening reach of point-of-care immunodiagnostics, the rising integration of AI-based result interpretation, and an intensified focus on preventive healthcare testing. Furthermore, significant trends during this period include a greater adoption of automated immunoassay analyzers, an escalating demand for high-sensitivity diagnostic tests, the increasing application of rapid immunodiagnostic kits, an expansion of multiplex testing capabilities, and enhanced integration of laboratory data management systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which Major Factors Are Driving The Expansion Of The Immunodiagnostics Market?

The expanding occurrence of chronic illnesses is anticipated to drive the future growth of the immunodiagnostics market. These are enduring health conditions, including diabetes, heart disease, and arthritis, typically advancing gradually and necessitating continuous medical care and lifestyle adjustments to manage symptoms and avert complications. Their rise is primarily linked to unhealthy lifestyle choices, such as inadequate diet, lack of physical activity, and smoking, which heighten the likelihood of developing conditions like diabetes, heart disease, and obesity. Immunodiagnostic methods assist in diagnosing chronic diseases by facilitating precise identification of biomarkers and immune reactions tied to prolonged health issues. These tools improve the early recognition and tracking of conditions like diabetes, autoimmune disorders, and cardiovascular issues, leading to better patient care and informed treatment choices. As an example, in June 2024, data from the UK’s National Health Service indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by high blood sugar levels below the diabetes threshold) in 2023. This represented an 18% increase from 3,065,825 cases recorded in 2022. Consequently, the growing incidence of chronic and infectious diseases is fueling the expansion of the immunodiagnostics market.

How Are The Various Segments Of The Immunodiagnostics Market Categorized?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, ELISA Readers

What Trends Are Affecting The Expansion Of The Immunodiagnostics Market?

Key players in the immunodiagnostics market are increasingly prioritizing the creation of advanced solutions, such as automated chemiluminescence immunoassays (CLIAs), to elevate diagnostic accuracy, shorten testing periods, and optimize laboratory productivity. Automated chemiluminescence immunoassays (CLIAs) are laboratory tests that employ light-emitting chemical reactions and automation to swiftly and precisely detect specific proteins or antibodies in blood or other samples. An example of this trend is DiaSorin S.p.A., an Italy-based diagnostics company, which introduced the LIAISON® TSH-R Ab assay for autoimmune thyroid disorder assessment in September 2025. This test features enhanced antibody specificity achieved through its double-bridge assay architecture, effortless integration into existing LIAISON analyzers to streamline laboratory processes, and CE-marked compatibility, enabling its use across multiple regulated regions.

Which Major Firms Influence Developments In The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

Read the full immunodiagnostics market report here:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunodiagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795